I wonder if after buying the Drogenbos facility in Belgium from Delpharm, Besins could be having issues with producing two different gels, cross contamination? This is just speculation, so don't worry 😉
Delpharm was responsible for the production of Oestrogel/Oestrodose for Besins and Estreva Gel for Theramex.
Estreva Gel is not marketed in the UK but has been marketed for decades in other countries, including France, initially by Teva and now by Theramex.
The issue is that Delpharm is a huge CDMO (Contract Development and Manufacturing Organization) that has many large pharmaceutical companies as customers, but Besins is only a medium-sized pharmaceutical company.
I wonder if they are having trouble making both gels because Estreva has a different amount of estradiol as well as other ingredients.
The most recent product leaflets for Estreva Gel list Besins Manufacturing Belgium as the manufacturer.
The ingredients from the French PIL:
'Estradiol hémihydraté...... 1,0325 mg
Ethanol à 96 pour cent, eau purifiée, propylène glycol, éther monoéthylique de diéthylène glycol (Transcutol), carbomère (Carbopol 1382), trolamine, édétate disodique.'
Propylene glycol, diethylene glycol monoethyl ether (Transcutol), a different carbomer (Carbopol 1382) and ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA dissodium) are not present in Oestrogel.